The Neuroprotective Properties of Palmitoylethanolamine Against Oxidative Stress in a Neuronal Cell Line

Overview

Journal Mol Neurodegener

Publisher Biomed Central

Specialties Molecular Biology
Neurology

Date 2009 Dec 17

PMID 20003317

Citations 24

Authors

R Scott Duncan

Kent D Chapman

Peter Koulen

Affiliations

Soon will be listed here.

Abstract

Background: N-acylethanolamines (NAEs) are lipids upregulated in response to cell and tissue injury and are involved in cytoprotection. Arachidonylethanolamide (AEA) is a well characterized NAE that is an endogenous ligand at cannabinoid and vanilloid receptors, but it exists in small quantities relative to other NAE types. The abundance of other NAE species, such as palmitoylethanolamine (PEA), together with their largely unknown function and receptors, has prompted us to examine the neuroprotective properties and mechanism of action of PEA. We hypothesized that PEA protects HT22 cells from oxidative stress and activates neuroprotective kinase signaling pathways.

Results: Indeed PEA protected HT22 cells from oxidative stress in part by mediating an increase in phosphorylated Akt (pAkt) and ERK1/2 immunoreactivity as well as pAkt nuclear translocation. These changes take place within a time frame consistent with neuroprotection. Furthermore, we determined that changes in pAkt immunoreactivity elicited by PEA were not mediated by activation of cannabinoid receptor type 2 (CB2), thus indicating a novel mechanism of action. These results establish a role for PEA as a neuroprotectant against oxidative stress, which occurs in a variety of neurodegenerative diseases.

Conclusions: The results from this study reveal that PEA protects HT22 cells from oxidative stress and alters the localization and expression levels of kinases known to be involved in neuroprotection by a novel mechanism. Overall, these results identify PEA as a neuroprotectant with potential as a possible therapeutic agent in neurodegenerative diseases involving oxidative stress.

Citing Articles

Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies.

Duncan R, Riordan S, Gernon M, Koulen P Neural Regen Res. 2023; 19(4):788-799.

PMID: 37843213 PMC: 10664133. DOI: 10.4103/1673-5374.382220.

A metabolome atlas of mouse brain on the global metabolic signature dynamics following short-term fasting.

Shao Y, Fu Z, Wang Y, Yang Z, Lin Y, Li S Signal Transduct Target Ther. 2023; 8(1):334.

PMID: 37679319 PMC: 10484938. DOI: 10.1038/s41392-023-01552-y.

-acylethanolamide metabolizing enzymes are upregulated in human neural progenitor-derived neurons exposed to sub-lethal oxidative stress.

Duncan R, Riordan S, Hall C, Payne A, Chapman K, Koulen P Front Cell Neurosci. 2022; 16:902278.

PMID: 36003139 PMC: 9393304. DOI: 10.3389/fncel.2022.902278.

Application of Metabolomics in Pediatric Asthma: Prediction, Diagnosis and Personalized Treatment.

Papamichael M, Katsardis C, Sarandi E, Georgaki S, Frima E, Varvarigou A Metabolites. 2021; 11(4).

PMID: 33919626 PMC: 8072856. DOI: 10.3390/metabo11040251.

Effects of Tacrolimus and Other Immune Targeting Compounds on Binge-Like Ethanol Drinking in High Drinking in the Dark Mice.

Grigsby K, Savarese A, Metten P, Mason B, Blednov Y, Crabbe J Neurosci Insights. 2020; 15:2633105520975412.

PMID: 33294845 PMC: 7705291. DOI: 10.1177/2633105520975412.

References

Derkinderen P, Valjent E, Toutant M, Corvol J, Enslen H, Ledent C . Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci. 2003; 23(6):2371-82. PMC: 6742049. View

Nilsen J, Chen S, Brinton R . Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res. 2002; 930(1-2):216-34. DOI: 10.1016/s0006-8993(02)02254-0. View

Schmid P, Kuwae T, Krebsbach R, SCHMID H . Anandamide and other N-acylethanolamines in mouse peritoneal macrophages. Chem Phys Lipids. 1997; 87(2):103-10. DOI: 10.1016/s0009-3084(97)00032-7. View

Hwang J, Duncan R, Madry C, Singh M, Koulen P . Progesterone potentiates calcium release through IP3 receptors by an Akt-mediated mechanism in hippocampal neurons. Cell Calcium. 2008; 45(3):233-42. PMC: 2860454. DOI: 10.1016/j.ceca.2008.10.006. View

Lambert D, Di Marzo V . The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?. Curr Med Chem. 1999; 6(8):757-73. View

Bouaboula M, Bourrie B, Canat X, Calandra B, Le Fur G, Casellas P . Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J. 1995; 312 ( Pt 2):637-41. PMC: 1136308. DOI: 10.1042/bj3120637. View

Chen Y, Buck J . Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J Pharmacol Exp Ther. 2000; 293(3):807-12. View

Bidaut-Russell M, Devane W, Howlett A . Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J Neurochem. 1990; 55(1):21-6. DOI: 10.1111/j.1471-4159.1990.tb08815.x. View

Singh M . Progesterone-induced neuroprotection. Endocrine. 2006; 29(2):271-4. DOI: 10.1385/ENDO:29:2:271. View

10.

Manning B, Cantley L . AKT/PKB signaling: navigating downstream. Cell. 2007; 129(7):1261-74. PMC: 2756685. DOI: 10.1016/j.cell.2007.06.009. View

11.

Koulen P, Madry C, Duncan R, Hwang J, Nixon E, McClung N . Progesterone potentiates IP(3)-mediated calcium signaling through Akt/PKB. Cell Physiol Biochem. 2008; 21(1-3):161-72. DOI: 10.1159/000113758. View

12.

Gomez Del Pulgar T, Velasco G, Guzman M . The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J. 2000; 347(Pt 2):369-73. PMC: 1220968. DOI: 10.1042/0264-6021:3470369. View

13.

Hansen H, Lauritzen L, Strand A, Moesgaard B, Frandsen A . Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. Biochim Biophys Acta. 1995; 1258(3):303-8. DOI: 10.1016/0005-2760(95)00134-x. View

14.

Sanchez M, Ruiz-Llorente L, Sanchez A, Diaz-Laviada I . Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cell Signal. 2003; 15(9):851-9. DOI: 10.1016/s0898-6568(03)00036-6. View

15.

Du K, Montminy M . CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem. 1998; 273(49):32377-9. DOI: 10.1074/jbc.273.49.32377. View

16.

Luo Y, DeFranco D . Opposing roles for ERK1/2 in neuronal oxidative toxicity: distinct mechanisms of ERK1/2 action at early versus late phases of oxidative stress. J Biol Chem. 2006; 281(24):16436-42. DOI: 10.1074/jbc.M512430200. View

17.

Rueda D, Galve-Roperh I, Haro A, Guzman M . The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol. 2000; 58(4):814-20. DOI: 10.1124/mol.58.4.814. View

18.

Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R . Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem. 1993; 61(1):352-5. DOI: 10.1111/j.1471-4159.1993.tb03576.x. View

19.

Skaper S, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L . The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A. 1996; 93(9):3984-9. PMC: 39472. DOI: 10.1073/pnas.93.9.3984. View

20.

Shouman B, Fontaine R, Baud O, Schwendimann L, Keller M, Spedding M . Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. Br J Pharmacol. 2006; 148(4):442-51. PMC: 1751782. DOI: 10.1038/sj.bjp.0706755. View